Resmed (RMD) Capital Expenditures (2009 - 2026)

Resmed's Capital Expenditures history runs 18 years deep, the most recent figure standing at $33.7 million for Q1 2026.

• Quarterly Capital Expenditures rose 61.83% year-over-year to $33.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $135.7 million (up 61.29% YoY) and the FY2025 annual result came in at $89.9 million, down 9.65% from the prior year.
• Capital Expenditures was $33.7 million for Q1 2026 at Resmed, up from $28.5 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $48.4 million in Q1 2022 and bottomed at $17.8 million in Q3 2024.
• A 5-year average of $28.9 million and a median of $28.6 million in 2022 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2024 — Capital Expenditures plunged 40.6% — and 2025, when it jumped 140.84%.
• Resmed's Capital Expenditures stood at $27.4 million in 2022, then fell by 14.61% to $23.4 million in 2023, then fell by 11.6% to $20.6 million in 2024, then jumped by 38.24% to $28.5 million in 2025, then advanced by 17.92% to $33.7 million in 2026.
• Business Quant data shows RMD's Capital Expenditures at $33.7 million in Q1 2026, $28.5 million in Q4 2025, and $43.0 million in Q3 2025.